The store will not work correctly when cookies are disabled.
5-(3,4,5-Trimethoxy-phenyl)-2,3-dihydro-imidazo[2,1-a]isoquinoline
ID: ALA81384
PubChem CID: 10246399
Max Phase: Preclinical
Molecular Formula: C20H20N2O3
Molecular Weight: 336.39
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(C2=Cc3ccccc3C3=NCCN23)cc(OC)c1OC
Standard InChI: InChI=1S/C20H20N2O3/c1-23-17-11-14(12-18(24-2)19(17)25-3)16-10-13-6-4-5-7-15(13)20-21-8-9-22(16)20/h4-7,10-12H,8-9H2,1-3H3
Standard InChI Key: ZNENOHIDSLSQCG-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
5.1042 -2.6792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5875 -2.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1375 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6250 -1.7667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7375 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0750 -2.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5875 -3.5792 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0917 -2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9292 -2.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6292 -2.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6250 -1.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -2.6125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0292 -1.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6250 -2.9792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6250 -3.5792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -2.0917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7792 -0.9917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9292 -3.1292 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5417 -2.9417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5792 -1.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9500 -1.6667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2917 -0.6875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5292 -3.1292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0292 -2.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0417 -2.0292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 1 1 0
4 3 2 0
5 3 1 0
6 2 1 0
7 2 2 0
8 4 1 0
9 11 1 0
10 12 1 0
11 13 2 0
12 5 2 0
13 5 1 0
14 1 1 0
15 14 1 0
16 9 1 0
17 11 1 0
18 10 1 0
19 6 1 0
20 8 1 0
21 16 1 0
22 17 1 0
23 18 1 0
24 19 2 0
25 20 2 0
15 7 1 0
8 6 2 0
9 10 2 0
24 25 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 336.39 | Molecular Weight (Monoisotopic): 336.1474 | AlogP: 3.29 | #Rotatable Bonds: 4 |
Polar Surface Area: 43.29 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 7.09 | CX LogP: 2.59 | CX LogD: 2.41 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.86 | Np Likeness Score: 0.05 |
References
1. Houlihan WJ, Munder PG, Handley DA, Cheon SH, Parrino VA.. (1995) Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines., 38 (2): [PMID:7830265] [10.1021/jm00002a004] |